Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04122625
Title Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 (SMARTPLUS-106)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Debiopharm International SA
Indications

endometrial cancer

lung small cell carcinoma

head and neck squamous cell carcinoma

peritoneum cancer

gastrointestinal system cancer

ovary epithelial cancer

Advanced Solid Tumor

cervical cancer

Therapies

Nivolumab + Xevinapant

Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.